WallStreetZenWallStreetZen

NASDAQ: ATNF
180 Life Sciences Corp Stock

$2.33+0.32 (+15.92%)
Updated Mar 28, 2024
ATNF Price
$2.33
Fair Value Price
$1.73
Market Cap
$1.99M
52 Week Low
$1.81
52 Week High
$51.30
P/E
-0.04x
P/B
-15.56x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$19.94M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-42.18
Operating Cash Flow
-$11M
Beta
0.49
Next Earnings
Mar 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ATNF Overview

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATNF scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATNF ($2.33) is overvalued by 34.7% relative to our estimate of its Fair Value price of $1.73 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ATNF ($2.33) is not significantly undervalued (34.7%) relative to our estimate of its Fair Value price of $1.73 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ATNF is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ATNF due diligence checks available for Premium users.

Be the first to know about important ATNF news, forecast changes, insider trades & much more!

ATNF News

Valuation

ATNF fair value

Fair Value of ATNF stock based on Discounted Cash Flow (DCF)
Price
$2.33
Fair Value
$1.73
Overvalued by
34.70%
ATNF ($2.33) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ATNF ($2.33) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ATNF is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATNF price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.04x
Industry
14.26x
Market
44.51x

ATNF price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-15.56x
Industry
6.21x

ATNF's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.2M
Profit Margin
0%
ATNF's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$5.3M
Liabilities
$5.4M
Debt to equity
-42.18
ATNF's short-term liabilities ($5.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATNF's short-term assets ($3.64M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATNF's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ATNF's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.2M
Investing
$0.0
Financing
$1.5M
ATNF's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ATNF vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ATNF$1.99M+15.92%-0.04x-15.56x
QLGN$2.07M0.00%-0.11x-1.26x
CNSP$1.90M-2.16%-0.04x-1.09x
ALLR$1.86M-3.83%-0.03x-0.68x
WINT$1.82M-3.80%-0.02x0.24x

180 Life Sciences Stock FAQ

What is 180 Life Sciences's quote symbol?

(NASDAQ: ATNF) 180 Life Sciences trades on the NASDAQ under the ticker symbol ATNF. 180 Life Sciences stock quotes can also be displayed as NASDAQ: ATNF.

If you're new to stock investing, here's how to buy 180 Life Sciences stock.

What is the 52 week high and low for 180 Life Sciences (NASDAQ: ATNF)?

(NASDAQ: ATNF) 180 Life Sciences's 52-week high was $51.30, and its 52-week low was $1.81. It is currently -95.46% from its 52-week high and 29.09% from its 52-week low.

How much is 180 Life Sciences stock worth today?

(NASDAQ: ATNF) 180 Life Sciences currently has 852,772 outstanding shares. With 180 Life Sciences stock trading at $2.33 per share, the total value of 180 Life Sciences stock (market capitalization) is $1.99M.

180 Life Sciences stock was originally listed at a price of $3,686.00 in Jun 27, 2017. If you had invested in 180 Life Sciences stock at $3,686.00, your return over the last 6 years would have been -99.94%, for an annualized return of -70.7% (not including any dividends or dividend reinvestments).

How much is 180 Life Sciences's stock price per share?

(NASDAQ: ATNF) 180 Life Sciences stock price per share is $2.33 today (as of Mar 28, 2024).

What is 180 Life Sciences's Market Cap?

(NASDAQ: ATNF) 180 Life Sciences's market cap is $1.99M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

180 Life Sciences's market cap is calculated by multiplying ATNF's current stock price of $2.33 by ATNF's total outstanding shares of 852,772.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.